{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:28Z","timestamp":1787022088197,"version":"build-2736575974"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Balloon pulmonary angioplasty improves prognosis by alleviating pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension, even with incomplete revascularization. However, hypoxia or the requirement for pulmonary vasodilators often remain even after pulmonary hypertension relief. With this cohort study, we aimed to examine whether complete revascularization by additional balloon pulmonary angioplasty on residual lesions, even after pulmonary hypertension relief, could resolve hypoxia or the requirement for pulmonary vasodilators. During complete revascularization with balloon pulmonary angioplasty in 42 patients with chronic thromboembolic pulmonary hypertension, we investigated therapeutic effects at baseline (T1), pulmonary hypertension relief phase (T2), and at 6 months post-final balloon pulmonary angioplasty (T3). The pulmonary hypertension relief phase was defined as the first time that a mean pulmonary artery pressure \u2264 25 mmHg or pulmonary vascular resistance \u2264 240 dyn-s\/cm\n                    <jats:sup>5<\/jats:sup>\n                    was reached in right heart catheterization before balloon pulmonary angioplasty. The partial pressure of oxygen increased progressively over T1, T2, and T3 (59.2\u00b18.5, 69.0\u00b19.7, and 80.0\u00b19.5 mmHg, respectively; P&lt;0.001 T2 vs. T3). Minimum oxygen saturation levels during the 6-minute walk distance test were 87% (81\u201289%), 88% (84\u201292%), and 91% (89\u201293.3%), respectively (P&lt;0.001 T2 vs. T3), with gradual increase in the 6-minute walk distance (346\u00b1125 m, 404\u00b190 m, 454\u00b1101 m, respectively; P&lt;0.001 T2 vs. T3). The percentages of patients using pulmonary vasodilators (54.8%, 45.2%, 4.8%, respectively; P&lt;0.001 T2 vs. T3) and requiring oxygen therapy (26%, 26%, 7%, respectively; P = 0.008 T2 vs. T3) decreased significantly without hemodynamic exacerbation or major complications. Despite the discontinuation of pulmonary vasodilators, mean pulmonary artery pressure improved (36.0 [31.0\u201241.3], 21.4\u00b14.2, 18.5\u00b13.6 mmHg, respectively; P&lt;0.001 T2 vs. T3). Complete revascularization with balloon pulmonary angioplasty beyond pulmonary hypertension relief benefits patients with chronic thromboembolic pulmonary hypertension; it may improve oxygenation and exercise capacity, and reduce the need for pulmonary vasodilators and oxygen therapy.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0254770","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T13:39:06Z","timestamp":1626442746000},"page":"e0254770","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["A pilot cohort study assessing the feasibility of complete revascularization with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6680-9932","authenticated-orcid":true,"given":"Shinya","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nagayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4263-6421","authenticated-orcid":true,"given":"Kazuo","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu D.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Minai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"pone.0254770.ref001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"N Galie","year":"2016","journal-title":"Eur Heart J"},{"issue":"Suppl 3","key":"pone.0254770.ref002","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1513\/AnnalsATS.201509-620AS","article-title":"The pathobiology of chronic thromboembolic pulmonary hypertension","volume":"13","author":"IM Lang","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"pone.0254770.ref003","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jtcvs.2010.11.024","article-title":"Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry","volume":"141","author":"E Mayer","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"pone.0254770.ref004","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jtcvs.2009.12.056","article-title":"Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension","volume":"141","author":"DH Freed","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"pone.0254770.ref005","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1164\/rccm.200712-1841OC","article-title":"Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension","volume":"177","author":"R Condliffe","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0254770.ref006","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/thoraxjnl-2013-203746","article-title":"Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy","volume":"69","author":"N Skoro-Sajer","year":"2014","journal-title":"Thorax"},{"key":"pone.0254770.ref007","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.115.019470","article-title":"Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort","volume":"133","author":"JE Cannon","year":"2016","journal-title":"Circulation"},{"key":"pone.0254770.ref008","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/icvts\/ivx424","article-title":"The outcome of reoperative pulmonary endarterectomy surgery","volume":"26","author":"JM Ali","year":"2018","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"pone.0254770.ref009","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcin.2013.03.009","article-title":"Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty","volume":"6","author":"T Inami","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"pone.0254770.ref010","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCINTERVENTIONS.112.971077","article-title":"Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension","volume":"5","author":"H Mizoguchi","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"pone.0254770.ref011","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1253\/circj.CJ-11-1217","article-title":"Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension","volume":"76","author":"K Sugimura","year":"2012","journal-title":"Circ J"},{"key":"pone.0254770.ref012","first-page":"2468","article-title":"Chronic thromboembolic pulmonary hypertension: Evolving therapeutic approaches for operable and inoperable Disease","volume":"71","author":"E Mahmud","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"pone.0254770.ref013","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2018.10.066","article-title":"Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy","volume":"278","author":"A Araszkiewicz","year":"2019","journal-title":"Int J Cardiol"},{"key":"pone.0254770.ref014","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1086\/675643","article-title":"Rescue balloon pulmonary angioplasty in a rapidly deteriorating chronic thromboembolic pulmonary hypertension patient with liver failure and refractory infection","volume":"4","author":"A Tsuji","year":"2014","journal-title":"Pulm Circ"},{"key":"pone.0254770.ref015","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1253\/circj.CJ-15-1212","article-title":"Multiple beneficial effects of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension","volume":"80","author":"S Tatebe","year":"2016","journal-title":"Circ J"},{"key":"pone.0254770.ref016","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12931-019-1211-y","article-title":"Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty","volume":"20","author":"Q Jin","year":"2019","journal-title":"Respir Res"},{"key":"pone.0254770.ref017","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/eurheartj\/ehx530","article-title":"Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications","volume":"38","author":"T Aoki","year":"2017","journal-title":"Eur Heart J"},{"key":"pone.0254770.ref018","doi-asserted-by":"crossref","first-page":"e004029","DOI":"10.1161\/CIRCOUTCOMES.117.004029","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: Results of a multicenter registry","volume":"10","author":"A Ogawa","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"pone.0254770.ref019","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1016\/j.jacc.2013.10.024","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"62","author":"NH Kim","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"pone.0254770.ref020","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1253\/circj.CJ-18-0258","article-title":"After the dawn- balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension","volume":"82","author":"A Ogawa","year":"2018","journal-title":"Circ J"},{"key":"pone.0254770.ref021","doi-asserted-by":"crossref","first-page":"e003318","DOI":"10.1161\/CIRCINTERVENTIONS.115.003318","article-title":"Novel angiographic classification of each vascular lesion in chronic thromboembolic pulmonary hypertension based on selective angiogram and results of balloon pulmonary angioplasty","volume":"9","author":"T Kawakami","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"pone.0254770.ref022","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcin.2019.01.237","article-title":"Balloon pulmonary angioplasty (percutaneous transluminal pulmonary angioplasty) for chronic thromboembolic pulmonary hypertension: a Japanese perspective","volume":"12","author":"M Kataoka","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"pone.0254770.ref023","doi-asserted-by":"crossref","first-page":"e005884","DOI":"10.1161\/CIRCINTERVENTIONS.117.005884","article-title":"Vascular injury is a major cause of lung injury after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension","volume":"11","author":"K Ejiri","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"pone.0254770.ref024","doi-asserted-by":"crossref","first-page":"e006010","DOI":"10.1161\/CIRCINTERVENTIONS.117.006010","article-title":"Vessel stretching is a cause of lumen enlargement immediately after balloon pulmonary angioplasty: intravascular ultrasound analysis in patients with chronic thromboembolic pulmonary hypertension","volume":"11","author":"H Shimokawahara","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"pone.0254770.ref025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijcard.2019.04.080","article-title":"Balloon pulmonary angioplasty for symptomatic chronic thromboembolic disease without pulmonary hypertension at rest","volume":"289","author":"T Inami","year":"2019","journal-title":"Int J Cardiol"},{"key":"pone.0254770.ref026","doi-asserted-by":"crossref","first-page":"1901982","DOI":"10.1183\/13993003.01982-2019","article-title":"Exercise intolerance in chronic thromboembolic pulmonary hypertension after pulmonary angioplasty","volume":"56","author":"H Kikuchi","year":"2020","journal-title":"Eur Respir J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T13:39:39Z","timestamp":1626442779000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254770"}},"subtitle":[],"editor":[{"given":"Jignesh K.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0254770","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]}}}